Addex director equity strikes reset to $0.032
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Addex Therapeutics Ltd. (ADXN) director Jason Raleigh Nunn reported compensation-related adjustments on September 2, 2026 with no net change in his positions. He returned and simultaneously re-received 219,561 shares of Common Stock and 50,000 stock options, reflecting the Remuneration Committee’s decision to reprice the related strike and exercise prices to $0.032 per share while leaving all other terms unchanged. No Rule 10b5-1 trading plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock-option (Right to Buy) F3, F2 | 50,000 | $0.00 | $0.00 |
| Grant/Award | Stock-option (Right to Buy) F3, F2 | 50,000 | $0.00 | $0.00 |
| Disposition | Common Stock F1 | 219,561 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 219,561 | $0.00 | $0.00 |
Footnotes (3)
- F1. Represents 219,561 shares of common Stock listed on SIX Swiss Exchange acquired following the exercise of options. Of these shares, 128,238 were acquired on October 26, 2022 under the deferred strike price payment plan with an initial strike price of $0.16 per share and 91,323 were acquired on November 27, 2023 with an initial strike price of $0.053 per share. On September 2, 2026, following the implementation of the Remuneration Committee's decision, the Strike price of all units was reduced to $0.032. All the other terms of the deferred strike price payment plan remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the exchange act as applicable.The strike prices indicated in this section reflect the conversion from CHF to USD at an exchange rate of $1.2296 per CHF 1.00 as of September 2, 2026.
- F2. On September 2, 2026, following the implementation of the Remuneration Committee's decision, the exercise price of options was repriced to $0.032. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the exchange act as applicable.
- F3. The exercise price is reported in U.S. dollars and reflects the conversion from CHF to USD at an exchange rate of $1.2296 per CHF 1.00 as of September 2, 2026.
Key Figures
Key Terms
deferred strike price payment plan financial
exercise price financial
Rule 16b-6(d) regulatory
Rule 16b-3 regulatory
exercise price is reported in U.S. dollars financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ADXN director Jason Raleigh Nunn report on this Form 4?
What happened to the exercise price of Jason Raleigh Nunn’s ADXN options?
Was a Rule 10b5-1 trading plan involved in these ADXN transactions?
How were the ADXN strike prices converted to U.S. dollars?
AI-generated analysis. How Rhea-AI works. Not financial advice.